Back
Applovin Corp. Vs. Ultragenyx Pharmaceutical, Inc. Industry Stock Comparison
Buy
84
APP
Applovin Corp.
Last Price:
$686.48
Seasonality Move:
1.66%
Sell
37
RARE
Ultragenyx Pharmaceutical, Inc.
Last Price:
$36.75
Seasonality Move:
8.64%
Buy
84
Applovin Corp. (APP)
is a Buy
Is Applovin Corp. a Buy, Sell or Hold?
-
The current Applovin Corp. [APP] share price is $691.94. The Score for APP is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
-
APP is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
37
Ultragenyx Pharmaceutical, Inc. (RARE)
is a Sell
Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?
-
The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $36.38. The Score for RARE is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
APP Stock Price Chart
What is Applovin Corp.'s stock price today?
-
The Applovin Corp. share price today is $691.94Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APP is experiencing slight buying pressure.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical, Inc.'s stock price today?
-
The Ultragenyx Pharmaceutical, Inc. share price today is $36.38Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing slight selling pressure.
APP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 18.49 | Buy |
| Relative Strength Index (14 RSI): | 69.68 | Buy |
| Chaikin Money Flow: | 430918 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (547.08 - 647.64) | Buy |
| Bollinger Bands (100): | (439.04 - 643.68) | Buy |
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.84 | Buy |
| Relative Strength Index (14 RSI): | 62.77 | Buy |
| Chaikin Money Flow: | -414275 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (31.73 - 34.81) | Buy |
| Bollinger Bands (100): | (28.38 - 33.4) | Buy |
APP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 632.05 | Buy |
| 20-day SMA: | 590.87 | Buy |
| 50-day SMA: | 610.53 | Buy |
| 200-day SMA: | 433.39 | Buy |
| 8-day EMA: | 641.29 | Buy |
| 20-day EMA: | 610.52 | Buy |
| 50-day EMA: | 590.84 | Buy |
| 200-day EMA: | 462.15 | Buy |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34.78 | Buy |
| 20-day SMA: | 33.42 | Buy |
| 50-day SMA: | 32.79 | Buy |
| 200-day SMA: | 33.89 | Buy |
| 8-day EMA: | 35.02 | Buy |
| 20-day EMA: | 33.96 | Buy |
| 50-day EMA: | 32.94 | Buy |
| 200-day EMA: | 34.73 | Buy |
Applovin Corp. Earnings Growth & APP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.94 per share, and an increase next year of $3.46 per share.
Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.
Applovin Corp. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ultragenyx Pharmaceutical, Inc. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||